Catalyst Pharmaceuticals, Inc.

Skandinaviska Enskilda Banken AB (publ) CPRX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

263,353

Value ($000)

6,141

Weight

0.0%

2024 Q3 - 2025 Q4 (6 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	6,141	0.0%	263,353	12/31/2025
2025 Q3	11/7/2025	6,616	0.0%	335,500	9/30/2025
2025 Q2	8/13/2025	11,994	0.1%	552,700	6/30/2025
2025 Q1	5/7/2025	19,082	0.1%	786,900	3/31/2025
2024 Q4	2/10/2025	15,421	0.1%	731,900	12/31/2024
2024 Q3	11/7/2024	8,348	0.0%	419,900	9/30/2024